Overview

Effectiveness of Lobeline in Treating Symptoms of ADHD in Adult Patients

Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The study will evaluate the effectiveness of the nonstimulant medication lobeline in improving symptoms of attention deficit hyperactivity disorder in adults.
Phase:
Phase 2
Details
Lead Sponsor:
Yaupon Therapeutics
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Dopamine
Lobeline
Methylphenidate